<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08057018170791</udiDi>
    <basicUdiDi>805701817S10VA4</basicUdiDi>
    <tradeName>Viscorib Plus 1.0</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IROMED GROUP S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000031267</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S10V004V</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T03:52:35.120Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057018170807</udiDi>
    <basicUdiDi>805701817S15VAK</basicUdiDi>
    <tradeName>Viscorib Plus 1.5</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IROMED GROUP S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000031267</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S15V003V</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T03:52:35.101Z</lastUpdated>
  </row>
</eudamedExport>